Harvard Bioscience Cash Flow - Annual (NASDAQ:HBIO)

Add to My Stocks
$4.7 $0 (0%) HBIO stock closing price Feb 20, 2018 (Closing)

The Harvard Bioscience cash flow statement is one of the three reports that the company generates every quarter. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Harvard Bioscience profits one has to check the income statement and for Harvard Bioscience debt one has to check the balance sheet. Harvard Bioscience saw a cash impact of $- from the buyback of HBIO shares. The cash flow statement helps in the Harvard Bioscience stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Harvard Bioscience saw a outflow of $-0.06M from investing activities for 2016.

View details of Harvard Bioscience cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Net Income Cash Flow
-4.3M-19.03M2.35M-1.83M2.37M3.81M19.01M7.23M1.67M
Depreciation Depletion Amortization Cash-Flow4.36M4.65M3.93M4.03M4.25M4.41M4M3.45M3.36M
Net Increase (Decrease) in Assets Liabilities-0.04M-2.71M-4.51M1.94M--3.85M-1.23M5.2M-1.56M
Cash From (used in) Discontinued Operations----0.44M-1.34M---3.28M
Other Adjustments Net5.36M17.8M2.57M-2.52M2.27M-9.49M-2.44M
Net Cash from (used by) Operating Activities
5.38M-4.35M4.06M8.06M6.64M12.29M16.5M9.2M
Increase (Decrease) in Prop Plant And Equipment-1.44M-2.95M-0.86M-1.55M-1.73M-1.48M-0.81M-1.37M-1.3M
Acquisition Disposition of Subsidiaires1.41M-4.54M-12.65M1.78M-2.87M-5.46M-7.11M-20.76M-0.75M
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities-0.03M-0.01M--0.05M-0.06M-0.25M-0.41M-0.16M-0.56M
Net Cash from (used by) Investment Activities
-0.06M-7.51M-13.51M--4.67M-7.19M-8.34M-22.3M-2.62M
Issuance (Purchase) of Equity Shares-2.04M2.06M3.62M2.28M--4.71M-2.13M-1.68M
Issuance (Repayment) of Debt Securities-5.05M5.8M-3.3M11.8M-3.35M-1.7M4.68M13.22M-6.27M
Increase (Decrease) in Bank & Other Borrowings--8.35M------1.3M-
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities--0.03M--15.35M-----
Net Cash from (used by) Financing Activities
-4.86M-0.54M-1.23M--1.06M-1.14M-0.03M9.78M-7.95M
Effect of Exchange Rate Changes on Cash-1.6M-0.03M-1.23M---0.09M-0.8M-1.1M-3.12M
Net Change in Cash & Cash Equivalents
-1.14M-7.39M-11.63M5.09M2.76M-1.78M3.11M2.89M-4.5M
Cash & Equivalents at Beginning of Year6.74M14.13M25.77M20.68M17.91M19.7M16.58M13.69M18.2M
Cash & Equivalents at Year End5.59M6.74M14.13M25.77M20.68M17.91M19.7M16.58M13.69M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Harvard Bioscience stock price history and Harvard Bioscience stock comparison chart inevitably reflect its cash flow situation.

  • Harvard Bioscience saw a positive change in Net Change in Cash and Cash Equivalents of $-1.14M in 2016. Apart from the Harvard Bioscience stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $5.38M for HBIO.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.06M for HBIO in last 2016 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $-4.86M for Harvard Bioscience. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Harvard Bioscience Cash Flow

FCF margin
0.08

Annual Cash Flow Statements For Harvard Bioscience, Inc. Peers

Agilent cash flow, Danaher cash flow, MTS Systems cash flow, Newport cash flow, PerkinElmer cash flow